Kingdon Capital

Kingdon Capital

Kingdon Capital

Follow us
Alexa global traffic share
Latest investments Show all
$30,000,000
Post-IPO equity
SteadyMed Therapeutics
$2,000,000
Debt financing
Napo Pharmaceuticals
Team Size
1–10
Employees
Past year's investments

Kingdon Capital participated in fewer than 3 rounds over the past year

Latest rounds
  • SteadyMed Therapeutics: Post-IPO equity ($30M)
  • Napo Pharmaceuticals: Debt financing ($2M)
  • Mformation: Venture capital (Series E) ($20M)